S. aureus and Valve Replacement
To the Editor:
A recent case of native valve Staphylococcus aureus endocarditis at this institution stimulated us to consult, then re-evaluate the recent article by Richardson et al., which recommends that "patients who have staphylococcal endocarditis, regardless of hemodynamic state, should undergo valve replacement early to prevent the multiple complicating events associated with such infections and, therefore, improve survival."' This recommendation is, in part, based on their table 5, which shows that S. aureus caused seven deaths in 14 medically managed patients and three deaths in 14 surgical patients. These differences are not significant at the 0.05 level (chi square -Yates correction for subsets of small size).
To these cases of S. aureus endocarditis, the authors add 11 cases of Staphylococcus epidermidis endocarditis. Nine of these less-fatal infections (no deaths in 11 cases) occurred in the surgical group; only two occurred in the medical group. The authors combine the S. aureus and S. epidermidis data to show that Staphylococcal endocarditis caused seven deaths in 16 medically managed patients, compared with three deaths in 23 surgically managed patients (author's p = 0.03).
We suggest that a surgical group of 23 patients with staphylococcal endocarditis, 39% of which are infected with S. epidermidis, may not be comparable to a medically treated group of 16 patients, only 13% of which are infected with S. epidermidis.
The authors should be commended for drawing attention to the possibility that certain bacteriologically definable subgroups of patients with endocarditis might be better managed surgically. From table 5 of their article, 18 of 46 medically treated patients with endocarditis caused by gram-positive cocci died, compared with nine of 64 surgical patients (p < 0.01). These data suggest that surgical management of patients with endocarditis due to grampositive cocci may be superior to medical management. This hypothesis should be further evaluated. Circulation 58: 598, 1978 Survival After CABG in a Nonrandomized Population To the Editor:
We read with interest Hammermeister, DeRouen and Dodge's" 2 attempt to define the relationship between coronary artery bypass graft surgery (CABGS) and survival in a nonrandomized population by using statistical adjustment for confounding. However, limiting the analysis to certain clinical and hemodynamic parameters may not adequately remove confounding. In a study that involves health services, besides confounding arising from known risk factors of cigarette smoking,3 and lipids,4' ' it may also occur because of social class-related variables.6Ẁ hen the Boston Collaborative Drug Surveillance Program failed to adjust adequately for social class,"°they incorrectly concluded that the use of reserpine was associated with breast cancer. In the case of CABGS, a mechanism by which social class could confound is not difficult to postulate: Those patients with good medical insurance (associated with affluence) have a higher rate of bypass surgery because the insurance company will pay for the 963 procedure. For the same reason, they visit the doctor frequently and receive good medical management. On the other hand, because of financial barriers to care, lower class patients get neither bypass surgery nor good medical care for their hypertension and congestive heart failure. Thus, it is good management of comorbidity with or without surgery (and not the surgery itself) that improves survival.
Statistical adjustment for confounding without randomization in a clinical trial is a weaker research design than a randomized trial, even when all known confounders are included in the analysisthe results may be biased by unrecognized confounders. However, whenever variables known to influence outcomes in heart disease are ignored in a nonrandomized trial, the validity of the conclusions from that trial must be seriously questioned. RUSSELL The authors reply. To the Editor: Drs. Luepker and Kottke question whether the differences in survival between medically and surgically treated patients with coronary disease that we observed could have been due to differences in social class. No data relevant to social class were collected at the time of entry into Seattle Heart Watch. However, as a part of a study to assess the effect of coronary surgery on return to work (Am J Cardiol, in press) we surveyed these patients 2-7 years after entry into the Angiography Registry of Seattle Heart Watch. Responses were received from 83% of patients then alive. Mean educational level was 11.7 years in the surgical cohort and 11.1 years in the medical, a difference which is statistically significant (p < 0.05), but of relatively small magnitude. The distributions of job classifications in the two cohorts are given in table 1, and do not differ significantly.
We conclude that it is highly unlikely that differences in social class could have accounted for differences in survival. If there is
